Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Papastratis

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Langenbecks Archiv Fur Chirurgie|January 1, 1997
Fournier's gangrene: still highly lethalA J Papachristodoulou, G N Zografos, G Papastratis, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|February 2, 2008
Laparoscopic resection of large adrenal ganglioneuromaG N Zografos, K Kothonidis, C Ageli, et al.
Journal of Chemotherapy (Florence, Italy)|November 8, 2002
Etoposide, leucovorin (LV) and 5-fluorouracil (5-FU) in 5-FU+LV pre-treated patients with advanced colorectal cancerN Tsavaris, C Kosmas, K Gennatas, et al.
Journal of Chemotherapy (Florence, Italy)|August 28, 1998
Combined epirubicin, 5-fluorouracil and folinic acid vs no treatment for patients with advanced pancreatic cancer: a prospective comparative studyN Tsavaris, K Tentas, M Tzivras, et al.
Cancer Chemotherapy and Pharmacology|September 25, 2003
Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized studyN Tsavaris, N Ziras, C Kosmas, et al.
Chemotherapy|May 16, 2002
Irinotecan (CPT-11) in patients with advanced colon carcinoma relapsing after 5-fluorouracil-leucovorin combinationN B Tsavaris, A Polyzos, K Gennatas, et al.
Journal of Chemotherapy (Florence, Italy)|January 15, 2010
CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysisN Tsavaris, C Kosmas, N Papadoniou, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 16, 2007
Leucovorin and 5-fluorouracil versus levamisole and 5-fluorouracil as adjuvant chemotherapy in rectal cancerN Tsavaris, K Genatas, C Kosmas, et al.
Oncology Reports|September 18, 2004
Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancerN Tsavaris, K Gennatas, C Kosmas, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Langenbecks Archiv Fur Chirurgie|January 1, 1997
Fournier's gangrene: still highly lethalA J Papachristodoulou, G N Zografos, G Papastratis, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|February 2, 2008
Laparoscopic resection of large adrenal ganglioneuromaG N Zografos, K Kothonidis, C Ageli, et al.
Journal of Chemotherapy (Florence, Italy)|November 8, 2002
Etoposide, leucovorin (LV) and 5-fluorouracil (5-FU) in 5-FU+LV pre-treated patients with advanced colorectal cancerN Tsavaris, C Kosmas, K Gennatas, et al.
Journal of Chemotherapy (Florence, Italy)|August 28, 1998
Combined epirubicin, 5-fluorouracil and folinic acid vs no treatment for patients with advanced pancreatic cancer: a prospective comparative studyN Tsavaris, K Tentas, M Tzivras, et al.
Cancer Chemotherapy and Pharmacology|September 25, 2003
Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized studyN Tsavaris, N Ziras, C Kosmas, et al.
Chemotherapy|May 16, 2002
Irinotecan (CPT-11) in patients with advanced colon carcinoma relapsing after 5-fluorouracil-leucovorin combinationN B Tsavaris, A Polyzos, K Gennatas, et al.
Journal of Chemotherapy (Florence, Italy)|January 15, 2010
CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysisN Tsavaris, C Kosmas, N Papadoniou, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 16, 2007
Leucovorin and 5-fluorouracil versus levamisole and 5-fluorouracil as adjuvant chemotherapy in rectal cancerN Tsavaris, K Genatas, C Kosmas, et al.
Oncology Reports|September 18, 2004
Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancerN Tsavaris, K Gennatas, C Kosmas, et al.
Pageof 2